Coya Therapeutics (“Coya”) Appoints Industry and Drug Development Veteran, Dr. Fred Grossman, To President and Chief Medical Officer Succeeding Dr. Adrian Hepner Pharmi Web.COM

Jul 05, 2023•over 2 years ago

Position

President

Company

Coya Therapeutics

Fred Grossman

HoustonBiotechnology

Description

HOUSTON----Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics intended to enhance Treg function, today announced the appointment of Dr. Fred Grossman to its senior management team as President and Chief Medical Officer.","Dr

Company Information

Company

Coya Therapeutics

Location

Houston, Texas, United States

About

Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Coya Therapeutics (“Coya”) Appoints Industry and Drug Development Veteran, Dr. Fred Grossman, To President and Chief Medical Officer Succeeding Dr. Adrian Hepner Pharmi Web.COM

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information